Waters Corporation ($WAT) Stock Forecast: Up 5.1% Today

What is Waters Corporation?

Waters Corp (WAT) Bullish Movement Waters Corp (WAT) is a company specialized in analytical laboratory instruments and software for pharmaceutical, biotech, and research industries. The stock saw a notable bullish movement today.

Why is Waters Corporation going up?

WAT stock is up 5.1% on May 29, 2026 16:16

• Waters Corp (WAT) stock rose by 7.2% propelled by robust first-quarter financial results that surpassed analyst forecasts and optimistic full-year guidance.
• The successful incorporation of Becton, Dickinson and Company's Biosciences and Diagnostic Solutions business greatly contributed to revenue growth, resulting in heightened earnings predictions.
• Despite some concerns regarding valuation and long-term margins, the prevailing sentiment among analysts is optimistic, with a "Buy" rating indicating investor trust in the company's growth potential.
• The uptick in the stock price could be linked to strategic acquisitions by the company and favorable market sentiment towards its performance and future prospects.

WAT Price Chart

WAT Technical Analysis

WAT News

Agilent Technologies (A) Margin Gains Reinforce Bullish Recurring Revenue Narrative After Q2 2026 Results

Agilent Technologies reported strong Q2 2026 results with revenue of US$1.835 billion and EPS of US$1.20, driven by a significant 21.3% earnings growth over the last year. The company's net profit margin improved to 19.6% from 17.6% a year ago, which aligns with a bullish narrative supported by cost savings and an increasing mix of recurring revenue from consumables, software, and services. Despite slower forecast growth rates compared to the broader US market, the current stock price is below its DCF fair value and analyst targets, presenting a potential opportunity for investors.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/agilent-technologies-a-margin-gains-reinforce-bullish-recurr

Here’s Hinde Group’s Updates on Becton, Dickinson and Company (BDX)

Hinde Group released its Q1 2026 investor letter, detailing a 3.41% net return for its portfolio amidst market volatility caused by a "SaaS-pocalypse" and military actions against Iran. The letter highlights their "special situation investment" in Becton, Dickinson and Company (BDX), initiated in July 2025, and provides an overview of the medical technology company's recent performance and a Reverse Morris Trust transaction. Despite their position in BDX, Hinde Group suggests that certain AI stocks may offer greater and faster returns for investors.

https://www.insidermonkey.com/blog/heres-hinde-groups-updates-on-becton-dickinson-and-company-bdx-1770876/

Waters Corp (WAT) Stock Up 7.2% and Still Undervalued -- GF Scor

Waters Corp (WAT) shares recently rose 7.2% to $366.67, with GuruFocus indicating it's undervalued by 9.0% against its GF Value™ of $403.01, despite a year-to-date decline. The company boasts a strong GF Score™ of 91/100, particularly in profitability and growth, and recent insider buying signals confidence. However, its current P/E (TTM) of 46.6x is above its 5-year median, suggesting valuation caution is warranted alongside growth potential.

https://www.gurufocus.com/news/8889770/waters-corp-wat-stock-up-72-and-still-undervalued-gf-score-91100

Waters Corp Stock (WAT) Closed Up by 7.23% on May 28: What Investors Need To Know

Waters Corp (WAT) saw its stock close up by 7.23% on May 28, primarily driven by strong first-quarter 2026 financial results that exceeded analyst expectations and an optimistic full-year guidance. The company's successful integration of Becton, Dickinson and Company's Biosciences and Diagnostic Solutions business contributed significantly to revenue, leading to raised earnings and organic constant currency revenue growth projections. Despite some analyst caution regarding valuation and long-term margin impacts, the overall consensus remains positive with a majority "Buy" rating.

https://www.tradingkey.com/news/market-movers/261934359-market-movers-wat-20260528

Illumina's new fireflyGO robot targets faster cancer lab workflows

Illumina and SPT Labtech have launched fireflyGO, a new benchtop automation platform designed to streamline liquid handling and library preparation in targeted oncology research. Integrated with the MiSeq i100 Series, fireflyGO aims to make next-generation sequencing (NGS) more accessible and efficient for cancer testing. Additionally, Illumina is expanding its oncoReveal portfolio with new gene panels for solid tumor and lymphoid malignancies, all geared towards accelerating genomic characterization of various cancer types.

https://www.stocktitan.net/news/ILMN/illumina-and-spt-labtech-unveil-firefly-go-enabling-faster-simpler-uaipih9njx2d.html

Trending Today

Waters Corporation Price History

30.03.2026 - WAT Stock was up 5.4%

• Despite its recent underperformance against competitors, Waters Corp. stock displayed a bullish movement.
• Investor interest in Waters Corp. might have been ignited by ongoing merger activities within the industry.
• The stock's trading below its 52-week high potentially attracted bargain hunters seeking upward potential.
• The favorable market sentiment towards the sector likely contributed to the bullish movement in Waters Corp. stock.

30.03.2026 - WAT Stock was up 5.9%

• Vanguard Capital Management's significant ownership stake in Waters Corp likely boosted investor confidence, driving increased buying activity and pushing the stock price up.
• Previous underperformance of Waters Corp's stock compared to competitors may have presented an attractive buying opportunity, contributing to today's bullish trend.
• A shareholder alert about investigations into mergers at other companies could have shifted focus away from Waters Corp, enabling independent stock rallying.
• Market conditions and investor sentiment likely played a part in driving Waters Corp's stock upward, despite broader market downturns.

08.03.2026 - WAT Stock was up 5.9%

• The bullish movement in Waters Corp's stock (WAT) can be attributed to the following factors:
• Approval of Waters' at-home cervical cancer screening kit is a significant milestone, enhancing the company's product portfolio and potentially increasing its market share in the healthcare sector.
• The approval is expected to drive revenue growth as the kit allows for convenient at-home sample collection, catering to the un/under-screened population, thereby addressing a critical healthcare need.
• Waters Corp's strong market position in essential industries like drug discovery and environmental testing, coupled with its diversified portfolio and recurring revenue model, provides investors with confidence in its long-term growth prospects.
• Despite facing risks such as supply chain disruptions, the company's strategic focus on innovation and its role in critical industries position it favorably for sustained success in the market.

29.04.2026 - WAT Stock was up 5.1%

• Waters Corp (WAT) stock rose by 7.2% propelled by robust first-quarter financial results that surpassed analyst forecasts and optimistic full-year guidance.
• The successful incorporation of Becton, Dickinson and Company's Biosciences and Diagnostic Solutions business greatly contributed to revenue growth, resulting in heightened earnings predictions.
• Despite some concerns regarding valuation and long-term margins, the prevailing sentiment among analysts is optimistic, with a "Buy" rating indicating investor trust in the company's growth potential.
• The uptick in the stock price could be linked to strategic acquisitions by the company and favorable market sentiment towards its performance and future prospects.

23.03.2026 - WAT Stock was down 8.8%

• The bearish movement in Waters Corporation's stock today could be attributed to the spin-off of Becton Dickinson's biosciences and diagnostic solutions business, which was combined with Waters Corporation. This significant transaction valued at $18.8 billion might have raised concerns among investors about the potential impact on Waters Corporation's future performance and market positioning.
• Additionally, advancements in the healthcare industry, such as GE HealthCare's development of a manganese-based MRI contrast agent as an alternative to gadolinium-based agents, could have shifted investor focus towards companies directly involved in healthcare innovations, leading to a temporary dip in Waters Corporation's stock.
• The global Cloud ELN Service market's projected growth and emphasis on digital transformation in research, particularly with companies like Thermo Fisher Scientific and Agilent Technologies driving this evolution, might have diverted investor attention away from traditional laboratory equipment providers like Waters Corporation, contributing to the bearish movement in the stock.
• Overall, the market movement in Waters Corporation today could be a result of shifting investor sentiments towards healthcare innovation and digital laboratory transformation, impacting the company's stock performance in the short term.

27.02.2026 - WAT Stock was down 5.5%

• Waters Corp stock faced a bearish movement possibly due to growth challenges, despite favorable sector tailwinds.
• The company's mixed recent performance and analyst ratings leaning towards a "Moderate Buy" might have contributed to investor uncertainty and selling pressure.
• The bearish trend could also be influenced by the overall slowdown in the life sciences sector, indicating broader industry challenges impacting companies like Waters Corp.
• Investors may be cautious about the company's ability to navigate these growth challenges and maintain its competitive position in the market, leading to the bearish movement in the stock.

06.04.2026 - WAT Stock was up 5.3%

• Waters Corporation (WAT) experienced a strong bullish movement today following its impressive Q1 2026 earnings performance.
• The stock surged after reporting adjusted EPS of $2.70 and double-digit organic growth in its legacy businesses, surpassing market expectations.
• A price target increase to $370 by BofA Securities reflects confidence in the company's performance and growth prospects.
• The successful integration of newly acquired businesses and raised full-year guidance contributed to the positive sentiment surrounding Waters Corp, driving the stock's upward momentum.

05.04.2026 - WAT Stock was up 12.1%

• Waters Corporation (WAT) witnessed a significant upward trend in its stock performance today.
• The company exceeded market expectations in both adjusted EPS and revenue during the first quarter.
• The strong results were linked to the successful incorporation of its newly acquired Biosciences and Diagnostic Solutions divisions, driving organic growth and enhancing the overall positive sentiment.
• The company's decision to increase its projected figures for adjusted EPS and total revenue for the full year 2026 further boosted investor confidence, indicating sustained growth and profitability ahead.

05.04.2026 - WAT Stock was up 11.4%

• Waters Corporation (WAT) witnessed a strong bullish movement today, with its stock increasing over 5% in pre-market trading.
• The surge in WAT's stock price is attributed to the company's impressive first-quarter 2026 financial results, surpassing analyst expectations.
• Contributing factors to this bullish trend include the company's robust revenue of $1.27 billion, adjusted EPS of $2.70, and increased full-year 2026 guidance for both adjusted EPS and total revenue.
• The successful integration of its recent acquisition of Biosciences and Diagnostic Solutions, combined with strong organic growth, significantly influenced Waters Corporation's positive performance and investor confidence.

13.04.2026 - WAT Stock was down 5.0%

• Despite a mixed trading session in the market, Waters Corporation stock (WAT) saw a notable bearish movement.
• The underperformance of WAT relative to its competitors and its 52-week high indicates possible company-specific factors affecting its stock performance.
• The ongoing integration of Becton Dickinson's Biosciences and Diagnostic Solutions unit may be causing uncertainty among investors, contributing to the negative movement.
• An increase in short interest in Agilent Technologies Inc. amidst market pressures could also be influencing unfavorable sentiment towards WAT, further driving its downward trajectory.

28.04.2026 - WAT Stock was up 5.5%

• Today, Waters Corporation stock (WAT) displayed a bullish trend, demonstrating resilience amidst recent market fluctuations.
• The consistent need for analytical instruments and services, especially in pharmaceuticals and biopharma, contributed to the favorable market performance.
• While Waters Corporation trailed behind some competitors in recent trading sessions, its competitive edge in instrument performance and strong customer relationships continues to foster investor trust.
• The market outlook towards companies like Waters Corporation may have been positively influenced by the anticipation of Agilent Technologies Inc.'s earnings and the heightened focus on pharmaceutical manufacturing demand in the sector.

28.04.2026 - WAT Stock was up 6.0%

• Today, Waters Corporation stock (WAT) experienced a notable uptick of 1.05%, despite its previous underperformance against peers.
• The industry-wide upswing in the diagnostics and research sector, observed among companies like IQVIA Holdings Inc., might have influenced the positive movement in WAT.
• The consistent demand for analytical instruments and services in the pharmaceutical and biopharma sectors, highlighted in recent financial updates, likely bolstered investor optimism towards WAT.
• Investors are advised to monitor announcements from key sector players and assess whether the ongoing positive trend in the broader industry will continue to support the upward momentum of WAT.